CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration

被引:39
作者
Barth, PJ
Köster, H
Moosdorf, R
机构
[1] Univ Marburg, Inst Pathol, D-35033 Marburg, Germany
[2] Univ Marburg, Dept Cardiac Surg, D-35033 Marburg, Germany
关键词
mitral valve; myxomatous degeneration; CD34; fibrocytes;
D O I
10.1016/j.prp.2005.02.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We investigated a total of 15 mitral valves with myxomatous degeneration and compared these with normal mitral valves. In normal mitral valves, stromal cells located in the fibrosa and spongiosa showed small bipolar cytoplasmic processes and were found to be positive for CD34, suggesting a close relationship to CD34(+) fibrocytes. In cases of myxomatous degeneration, stromal cells showed an altered morphology in that they exhibited multipolar cytoplasmic processes, appeared to be hyperplastic, and were increased in number. This study is the first to report on CD34(+) fibrocytes making up the majority of mitral valve stromal cells. Major factors in the development of myxomatous valve degeneration are MMP-9, as well as collagen I and III, which have been reported to be secreted by CD34(+) fibrocytes. Therefore, it is likely that CD34(+) fibrocytes are involved in the pathogenesis of myxomatous mitral valve degeneration. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:301 / 304
页数:4
相关论文
共 21 条
[1]   Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites [J].
Abe, R ;
Donnelly, SC ;
Peng, T ;
Bucala, R ;
Metz, CN .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7556-7562
[2]   Immunolocalization of elastin, collagen type I and type III, fibronectin, and vitronectin in extracellular matrix components of normal and myxomatous mitral heart valve chordae tendineae [J].
Akhtar, S ;
Meek, KM ;
James, V .
CARDIOVASCULAR PATHOLOGY, 1999, 8 (04) :203-211
[3]  
ARETZ HT, 1999, DIAGNOSTIC SURG PATH, V1, P1209
[4]  
Barber JE, 2001, J HEART VALVE DIS, V10, P320
[5]   CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions [J].
Barth, PJ ;
Ebrahimsade, S ;
Ramaswamy, A ;
Moll, R .
VIRCHOWS ARCHIV, 2002, 440 (03) :298-303
[6]   CD34+fibrocytes in neoplastic and inflammatory pancreatic lesions [J].
Barth, PJ ;
Ebrahimsade, S ;
Hellinger, A ;
Moll, R ;
Ramaswamy, A .
VIRCHOWS ARCHIV, 2002, 440 (02) :128-133
[7]  
BILLINGHAM ME, 1997, HISTOLOGY PATHOLOGIS, P745
[8]   CIRCULATING FIBROCYTES DEFINE A NEW LEUKOCYTE SUBPOPULATION THAT MEDIATES TISSUE-REPAIR [J].
BUCALA, R ;
SPIEGEL, LA ;
CHESNEY, J ;
HOGAN, M ;
CERAMI, A .
MOLECULAR MEDICINE, 1994, 1 (01) :71-81
[9]   The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ [J].
Chesney, J ;
Bacher, M ;
Bender, A ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6307-6312
[10]  
Chesney J, 1998, J IMMUNOL, V160, P419